Header Logo

Connection

CARL ALLEN to Neoplasm, Residual

Back to Details
This is a "connection" page, showing publications CARL ALLEN has written about Neoplasm, Residual.
CARL ALLEN
Connection Strength
0.838
Neoplasm, Residual
  1. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood. 2024 05 16; 143(20):2053-2058.
    View in: PubMed
    Score: 0.838
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.